title: Improvement of psoriasis during imatinib therapy in a patient with a metastatic gastrointestinal stromal tumour.
authors.forename: S
authors.initials: S
authors.lastname: Miyagawa
authors.forename: H
authors.initials: H
authors.lastname: Fujimoto
authors.forename: S
authors.initials: S
authors.lastname: Ko
authors.forename: S
authors.initials: S
authors.lastname: Hirota
authors.forename: Y
authors.initials: Y
authors.lastname: Kitamura
mesh_terms: D001549:Benzamides; D003110:Colonic Neoplasms / Q000628:therapy; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy*; D006801:Humans; D000068877:Imatinib Mesylate; D008297:Male; D008875:Middle Aged; D009852:Omentum; D010534:Peritoneal Neoplasms / Q000556:secondary; D010879:Piperazines / Q000627:therapeutic use*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*; D011565:Psoriasis / Q000188:drug therapy*; D011743:Pyrimidines / Q000627:therapeutic use*; D013160:Splenic Neoplasms / Q000556:secondary
chemical_list: D001549:Benzamides; D004791:Enzyme Inhibitors; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate; D011505:Protein-Tyrosine Kinases